Discovery and characterization of stable and toxic Tau/phospholipid oligomeric complexes

Nadine Ait-Bouziad1, Guohua Lv2, Anne-Laure Mahul-Mellier1

  • 1Laboratory of Molecular and Chemical Biology of Neurodegeneration, Station 19, Ecole Polytechnique Fédérale de Lausanne, CH-1015, Lausanne, Switzerland.

Nature Communications
|November 23, 2017
PubMed

Insights

Tau protein interactions with cell membranes form toxic complexes, contributing to Alzheimer's disease pathogenesis. Researchers identified key Tau motifs involved and developed mutants to study these interactions.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Cell Biology

Background:

  • The microtubule-associated protein Tau is implicated in Alzheimer's disease pathogenesis.
  • Tau's interaction with membranes is suspected to influence its function and aggregation, but details are unclear.

Purpose of the Study:

  • To investigate the sequence determinants and consequences of Tau-membrane interactions.
  • To understand how Tau-phospholipid complexes form and their toxicity.

Main Methods:

  • Studied Tau interaction with vesicles to form protein/phospholipid complexes.
  • Utilized MC-1 antibody to detect pathological Tau conformations.
  • Employed Tau-derived peptides and designed mutants to disrupt membrane interactions.

Main Results:

  • Tau forms highly stable complexes with vesicles.
  • These complexes are toxic to primary hippocampal cultures.
  • The PHF6* and PHF6 hexapeptide motifs are central to these complexes, with PHF6 in a β-strand conformation.

Conclusions:

  • Tau-membrane interactions are mediated by specific hexapeptide motifs.
  • Disrupting these interactions can be achieved without preventing Tau fibril formation.
  • This research provides tools to decouple membrane interactions from fibril formation for further study of Tau's role in disease.

Related Concept Videos